Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
15 Pág. Centro de Investigación en Sanidad Animal (CISA)
| Autores: | , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/279181 |
| Acceso en línea: | http://hdl.handle.net/10261/279181 https://api.elsevier.com/content/abstract/scopus_id/85133214171 |
| Access Level: | acceso abierto |
| Palabra clave: | Attenuated Cold-adapted Ferrets Guinea pigs Influenza A virus Live-attenuated influenza vaccines Master donor virus Protection efficacy Temperature sensitive Transmission Vaccines |
| id |
ES_28d6e05e2eb45acbced101f536fcfaad |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/279181 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine |
| title |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine |
| spellingShingle |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine Nogales, Aitor Attenuated Cold-adapted Ferrets Guinea pigs Influenza A virus Live-attenuated influenza vaccines Master donor virus Protection efficacy Temperature sensitive Transmission Vaccines |
| title_short |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine |
| title_full |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine |
| title_fullStr |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine |
| title_full_unstemmed |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine |
| title_sort |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine |
| dc.creator.none.fl_str_mv |
Nogales, Aitor Steel, John Liu, Wen-Chun Lowen, Anice C. Rodriguez, Laura Chiem, Kevin Cox, Andrew García-Sastre, Adolfo Albrecht, Randy A. Dewhurst, Stephen Martínez-Sobrido, Luis |
| author |
Nogales, Aitor |
| author_facet |
Nogales, Aitor Steel, John Liu, Wen-Chun Lowen, Anice C. Rodriguez, Laura Chiem, Kevin Cox, Andrew García-Sastre, Adolfo Albrecht, Randy A. Dewhurst, Stephen Martínez-Sobrido, Luis |
| author_role |
author |
| author2 |
Steel, John Liu, Wen-Chun Lowen, Anice C. Rodriguez, Laura Chiem, Kevin Cox, Andrew García-Sastre, Adolfo Albrecht, Randy A. Dewhurst, Stephen Martínez-Sobrido, Luis |
| author2_role |
author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
New York Influenza Center of Excellence National Institute of Allergy and Infectious Diseases (US) Department of Health and Human Services (US) Centers of Excellence for Influenza Research and Surveillance (US) Department of Defense (US) Center for Research for Influenza Pathogenesis (US) Ministerio de Ciencia e Innovación (España) Icahn School of Medicine at Mount Sinai Nogales, Aitor [0000-0002-2424-7900] Lowen, Anice C. [0000-0002-9829-112X] Chiem, Kevin [0000-0002-3892-5944] García-Sastre, Adolfo [0000-0002-6551-1827] Albrecht, Randy A. [0000-0003-4008-503X] Dewhurst, Stephen [0000-0001-7729-7920] Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Attenuated Cold-adapted Ferrets Guinea pigs Influenza A virus Live-attenuated influenza vaccines Master donor virus Protection efficacy Temperature sensitive Transmission Vaccines |
| topic |
Attenuated Cold-adapted Ferrets Guinea pigs Influenza A virus Live-attenuated influenza vaccines Master donor virus Protection efficacy Temperature sensitive Transmission Vaccines |
| description |
15 Pág. Centro de Investigación en Sanidad Animal (CISA) |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2022 2022 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/279181 https://api.elsevier.com/content/abstract/scopus_id/85133214171 |
| url |
http://hdl.handle.net/10261/279181 https://api.elsevier.com/content/abstract/scopus_id/85133214171 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Microbiology spectrum https://doi.org/10.1128/spectrum.00078-22 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
ASM International |
| publisher.none.fl_str_mv |
ASM International |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869404969343385600 |
| spelling |
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus VaccineNogales, AitorSteel, JohnLiu, Wen-ChunLowen, Anice C.Rodriguez, LauraChiem, KevinCox, AndrewGarcía-Sastre, AdolfoAlbrecht, Randy A.Dewhurst, StephenMartínez-Sobrido, LuisAttenuatedCold-adaptedFerretsGuinea pigsInfluenza A virusLive-attenuated influenza vaccinesMaster donor virusProtection efficacyTemperature sensitiveTransmissionVaccines15 Pág. Centro de Investigación en Sanidad Animal (CISA)Influenza A viruses (IAV) remain emerging threats to human public health. Live-attenuated influenza vaccines (LAIV) are one of the most effective prophylactic options to prevent disease caused by influenza infections. However, licensed LAIV remain restricted for use in 2- to 49-year-old healthy and nonpregnant people. Therefore, development of LAIV with increased safety, immunogenicity, and protective efficacy is highly desired. The U.S.-licensed LAIV is based on the master donor virus (MDV) A/Ann Arbor/6/60 H2N2 backbone, which was generated by adaptation of the virus to growth at low temperatures. Introducing the genetic signature of the U.S. MDV into the backbone of other IAV strains resulted in varying levels of attenuation. While the U.S. MDV mutations conferred an attenuated phenotype to other IAV strains, the same amino acid changes did not significantly attenuate the pandemic A/California/04/09 H1N1 (pH1N1) strain. To attenuate pH1N1, we replaced the conserved leucine at position 319 with glutamine (L319Q) in PB1 and analyzed the in vitro and in vivo properties of pH1N1 viruses containing either PB1 L319Q alone or in combination with the U.S. MDV mutations using two animal models of influenza infection and transmission, ferrets and guinea pigs. Our results demonstrated that L319Q substitution in the pH1N1 PB1 alone or in combination with the mutations of the U.S. MDV resulted in reduced pathogenicity (ferrets) and transmission (guinea pigs), and an enhanced temperature sensitive phenotype. These results demonstrate the feasibility of generating an attenuated MDV based on the backbone of a contemporary pH1N1 IAV strain. IMPORTANCE Vaccination represents the most effective strategy to reduce the impact of seasonal IAV infections. Although LAIV are superior in inducing protection and sterilizing immunity, they are not recommended for many individuals who are at high risk for severe disease. Thus, development of safer and more effective LAIV are needed. A concern with the current MDV used to generate the U.S.-licensed LAIV is that it is based on a virus isolated in 1960. Moreover, mutations that confer the temperature-sensitive, cold-adapted, and attenuated phenotype of the U.S. MDV resulted in low level of attenuation in the contemporary pandemic A/California/04/09 H1N1 (pH1N1). Here, we show that introduction of PB1 L319Q substitution, alone or in combination with the U.S. MDV mutations, resulted in pH1N1 attenuation. These findings support the development of a novel LAIV MDV based on a contemporary pH1N1 strain as a medical countermeasure against currently circulating H1N1 IAV.This research was partially funded by the New York Influenza Center of Excellence (NYICE) (HHSN 272201400005C), and Emory-UGA (HHSN 272201400004C), members of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services, Centers of Excellence for Influenza Research and Surveillance (CEIRS) network. The work was also supported by grants W81XWH-18-1-0460-PRMRP-DA (to L.M.-S.) and W81XWH-17-1-0168 (to S.D.) from the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP), as well as NIH R01 AI145332-01 (to L.M.-S.). This research was also partly funded by NIAID grant P01AI097092, by CEIRR (Center for Research on Influenza Pathogenesis and Transmission), a NIAID funded Center of Excellence for Influenza Research and Response (CEIRR, contract # 75N93021C00014) and by the Collaborative Influenza Vaccine Innovation Centers NIAID contract 75N93019C00051 to AG-S. A.N. received a “Ramon y Cajal” Incorporation grant (RYC-2017) from the Spanish Ministry of Science, Innovation. Finally, A.C. received support from NIH grants T32GM068411 and T32GM007356. Use of the Zeiss AxioImager.Z2 microscope and image analysis was performed at the Microscopy CoRE at the Icahn School of Medicine at Mount Sinai.Peer reviewedASM InternationalNew York Influenza Center of ExcellenceNational Institute of Allergy and Infectious Diseases (US)Department of Health and Human Services (US)Centers of Excellence for Influenza Research and Surveillance (US)Department of Defense (US)Center for Research for Influenza Pathogenesis (US)Ministerio de Ciencia e Innovación (España)Icahn School of Medicine at Mount SinaiNogales, Aitor [0000-0002-2424-7900]Lowen, Anice C. [0000-0002-9829-112X]Chiem, Kevin [0000-0002-3892-5944]García-Sastre, Adolfo [0000-0002-6551-1827]Albrecht, Randy A. [0000-0003-4008-503X]Dewhurst, Stephen [0000-0001-7729-7920]Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202220222022info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/279181https://api.elsevier.com/content/abstract/scopus_id/85133214171reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)InglésMicrobiology spectrumhttps://doi.org/10.1128/spectrum.00078-22Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2791812026-05-22T06:33:51Z |
| score |
15,811543 |